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Summary.-Newborn A, C57BL, DBAf and IF mice were injected s.c. with a range
of doses of N-ethyl-N-nitrosourea (ENU). A high proportion of treated mice
developed tumours, particularly hepatomata, pulmonary adenomata and carcino-
mata, and malignant lymphomata of thymus and spleen. Liver tumours occurred
most frequently in C57BL and DBAf mice, lung tumours in A mice, and lymphomata
in A and DBAf mice. A small proportion of C57BL, DBAf and IF mice developed
tumours of the nervous system. The results are discussed with reference to the
ready induction of nervous system tumours in similarly treated rats, and their
relevance for human cancer.
CARCINOGENS of the nitrosamide type
induce tumours in many organs in experi-
mental animals, but particular interest
has been shown in their ability to induce
tumours of the central and peripheral
nervous systems. The carcinogen which
has been extensively used in these experi-
ments has been N-ethyl-N-nitrosourea
(ENU), and as the experimental animal,
most studies have used the rat, in which
nervous system tumours are induced in
up to 100% of animals following exposure
to a relatively small single dose of ENU
in late foetal life (Ivankovic and Druckrey,
1968) or in the immediate neonatal period
(Druckrey, Schagen and Ivankovic, 1970;
Jones, Searle and Smith, 1973).
In other species, brain tumours re-
sulted from repeated treatment of the
rabbit (Stavrou, 1969) and the dog
(Warzok et al., 1970) with N-methyl-N-
nitrosourea (MNU), but results of a
number of studies rather surprisingly
indicated that nervous system tumours
cannot be induced in this way in the
mouse. Treatment of mice with MNU
has been reported to give rise to leukaemia
(Graffi and Hoffmann, 1966), malignant
lymphoma (Terracini and Stramignoni,
1968), lymphomata, lung adenomata and
hepatomata (Terracini and Testa, 1970)
or to benign bronchial adenomata (Eckert
and Seidler, 1971). Even when newborn
mice were injected intracerebrally with
MNU, only leukaemias and lung tumours,
but no brain tumours, resulted (Kelly et
al., 1968). Similarly, transplacental ad-
ministration of ENU, which efficiently
induces neural tumours in rats, only
resulted in lung tumours in mice (Rice,
1969).
We were led by this species difference
in response to MNU and ENU to carry
out experiments on the effects of ENU
administered once neonatally to mice
of the 4 inbred strains maintained in
the Department of Cancer Studies. We
were most interested to find a small
number of neural tumours in mice of
the DBAf and IF strains, and a brief
account of the first 10 mice with such
tumours has been published (Searle and
Jones, 1972). By the end of the experi-
ment the total had risen to 14, including
one C57BL mouse.
However, as in other recently reportedCARCINOGENESIS BY ENU IN MICE
studies (Vesselinovitch et al., 1971, 1974;
Diwan and Meier, 1974), neural tumours
represented only a small proportion of
the tumours induced. The principal sites
of tumours in the experiment described
here were the liver, lung and lymphoid
system. Their location depended mark-
edly on strain and many mice had mul-
tiple primary tumours. Brief reports
were presented earlier (Searle and Jones,
1973, 1974).
MATERIALS AND METHODS
N-Ethyl-N-nitrosourea (ENU).-This was
prepared by nitrosation of ethylurea as
already described (Jones et at., 1973). As
day-old mice weigh onlyabout 1-5 g, however,
solutions were prepared for injection con-
taining the desired dose per g body-weight
dissolved in 0-02 ml instead of 0-01 ml to
enable a slightly larger and more controllable
volume to be injected.
Experimental animals.-Four strains of
mouse were employed for these experiments:
A/Bcr, C57BL/Bcr, DBAf/Bcr and IF/Bcr.
They were housed on sawdust in plastic
cages with tap water available ad libitum
throughout. They were fed Oxoid breeding
diet (Oxo Ltd., London) supplemented by a
commercial hamster mix until they were
6 weeks old, after which they received
Thompson diet 42 (Heygates Ltd., Bugbrooke
Mills, Northants).
Mice were injected s.c. when they were
1 day old with freshly prepared ENU solu-
tion using a size 20-25 G 16-mm needle.
Mice generally weighed about 1-5 g, the
volume administered then being 0-03 ml.
Trhe injection solution formed a short-lived
blister on the back of the neck, and the
young animals were kept apart from their
mothers for some 20 min to prevent
possible loss of solution through licking.
Control mice were treated similarly with
saline solution.
A careful watch was kept on the mice,
and sick animals or those appearing to bear
tumours were killed for examination. Never-
theless, 12 mice were lost to post mortem
examination through unexpected death and
decomposition. Tumours, and other tissues
appearing to warrant histological examina-
tion, were fixed in FAM (formalin-acetic
acid-methanol, 1 1: 8 by volume) and
embedded in paraffin wax. Sections (5 ,um)
were stained routinely with Harris' haemat-
oxylin and eosin and additionally with
special stains as required. Because of the
particular interest attaching to tumours in
the nervous system, brains of all the mice
were also processed and examined routinely.
With a few exceptions, surviving animals
were killed for examination at 80 weeks.
RESULTS
The Table summarizes our results
on the mice of each strain treated neo-
natally with ENU doses ranging from
0 mg/kg (saline controls) to 160 mg/kg:
numbers of mice treated, surviving to
6weeks, and examined post mortem,
numbers bearing tumours of various
types, and found tumour-free at death.
The median number of weeks from
treatment to death for each group of
mice is shown in parenthesis, and the
sign t indicates the presence of additional
primary tumours in at least half the
animals.
Survival of control and treated mice
Most control mice of the A, C57BL
and DBAf strains survived well to the
end of the experiment, but many controls
in the less robust IF strain died or had
to be killed from 45 weeks onwards
(see Table).
In the ENU-treated mice, overall
survival at 6 weeks was highest in -the
A strain mice (83.4%) and lowest in
the C57BL (42.3%). The proportion of
mice which were tumour-free at death
(last column of Table) tended to be
lowest at intermediate rather than high
dosages, but this was due to more mice
dying relatively early after the higher
dosages. Apart from its tumour-inducing
action, the ENU treatment was thus
associated also with a shortening of life
span, and many treated mice, particularly
A and IF, also showed evidence of lung
and other infections.
In a further experiment (not shown
in the Table) some strain A mice received
ENU at 80 mg/kg on each of the 1st,
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2nd and 3rd days after birth. Their
6-week survival was 11/18, but most
of the survivors died tumour-free between
16 and 30 weeks. The only tumours
found were lymphomata in 2 animals
at 18 and 22 weeks and an injection site
sarcoma in another at 25 weeks. Though
the divided dose was better tolerated
than would be expected for a single dose
of this magnitude it was thus still too
toxic to allow good survival and de-
velopment of many tumours. For the
single neonatal dose technique, the most
favourable dose range in the mouse
appears to be 20-80 mg/kg.
Tumours
A major proportion of the mice
treated neonatally with ENU developed
tumours. These were predominantly
liver, lung and lymphoid tumours but
also included a number of tumours in
the central and peripheral nervous sys-
tems, female reproductive tract, kidney
and some other sites (Table). There
were 6 mice with tumours among the 58
controls examined post mortem.
As is clear from the Table, the pro-
portions of tumours induced at different
sites showed marked dependence on strain.
Thus, liver tumours occurred predomin-
antly in C57BL and DBAf mice and
lymphoid tumours in A and DBAf mice.
Though lung tumours occurred in all
strains these tended to remain small
except in the A mice. With one excep-
tion, the nervous system tumours were
found only in DBAf and IF mice.
Multiple primary tumours
A noticeable feature ofthis experiment
was the high proportion of treated mice
which developed primary tumours of
more than one type. Additional primary
tumours were present in over 40% of
mice with liver or lung tumours and in
about 15% of those with lymphomata.
Liver and lung tumours often occurred
together but a variety of other combina-
tions was seen. Where more than half
of the mice in a group had two or more
primary tumours, this is indicated in the
Table.
Of the mice with more than 2 primary
tumours, the most interesting was the
only C57BL mouse to develop a tumour
of the nervous system. In addition to
a schwannoma of a peripheral nerve,
this animal had primary tumours of the
liver and lung and a renal cell carcinoma.
The lung tumour consisted of compact
small round cells with regular round or
oval nuclei. Acinar differentiation was
not marked and occasional pleomorphic
nuclei and mitoses were found. The
tumour was classified as a pulmonary
adenoma of alveolar lining cells. The
liver tumour was a histologically benign
hepatoma. The hepatic architecture was
replaced by sheets of large hepatocytes
tending to be arranged in cords and
trabeculae.
In contrast, the renal and peripheral
nervous system tumours were histologic-
ally malignant. The renal tumour con-
sisted of tightly packed alveolar or
acinar collections of tall columnar clear
cells traversed by thin fibrovascular tra-
beculae (Fig. 1). A moderate number of
mitoses were present. Histologically this
tumour closely resembled the clear-cell
carcinoma of kidney in humans. The
peripheral nerve tumour was a malignant
schwannoma (Fig. 2) as described below.
Nervous system tumours
Fifteen tumours of the nervous system
were found in 14 animals (overall in-
cidence 5-74%), all but one of which
were DBAf (11.10%) or IF (9.27%)
mice. Nine tumours were classified as
malignant schwannomata located in the
spinal or cranial nerves. One of these
tumours originated from the trigeminal
ganglion and was a mixed schwannoma
and neuroblastoma similar to the tri-
geminal nerve tumours observed in Wistar-
derived rats (Jones et al., 1973). This
mixed tumour consisted of interlacing
spindle cells, intermixed with densely
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FIG. 1.-Renal cell carcinoma, one of 4 primary tumours in a male
neonatal ENU. The tumour consists of alveoli of tall columnar
fibrovascular trabeculae. H. and E. x 335.
C57BL mouse, 54 weeks after
clear cells traversed by thin
I ..... ,
. ..
FIG. 2.-Malignant schwannoma of peripheral nerve in the same C57BL mouse as Fig. 1, showing
interlacing fascicles of spindle shaped cells and numerous mitoses. H. and E. x 335.
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cellular areas composed of small round
basophilic cells which formed charac-
teristic neuroblastoma rosettes. Two of
the schwannomata were well-differenti-
ated tumours composed of tightly inter-
woven fascicles of elongated spindle-
shaped cells (Fig. 2) showing numerous
mitoses and infiltration. The tumour
illustrated in Fig. 2 was one of the 4
primary tumours in the C57BL mouse
mentioned above. The other peripheral
nerve tumours were poorly-differentiated
schwannomata with little tendency to
palisading and with abundant evidence
of infiltration of the adjacent paraspinal
muscles.
The 4 brain tumours were located in
the cerebellum, in marked contrast to
the various reported findings in rats.
The 3 tumours in IF mice were medullo-
blastomata and that in a DBAf mouse
was a mixed oligoastrocytoma. The med-
ulloblastomata were densely cellular tu-
mours consisting of tightly packed small
round or oval cells (Fig. 3) showing
primitive and well-formed cellular ro-
settes. These tumours showed extension
along the molecular layer ofthe cerebellum
and a distinct origin could be demon-
strated from the internal granular layer.
In all 3 tumours persistent foetal external
granular layer was also present. The
observed origin of these experimental
tumours tends to substantiate one of the
traditional views of the histogenesis of
human cerebellar medulloblastomata.
Some of these tumours were recorded
in a preliminary report (Searle and
Jones, 1972) a more detailed account of
their neuropathological features is in press
(Jones et al., 1976).
Liver tumours
These were found in 65% of C57BL
mice examined post mortem, figures for
other strains being: A, 11%; DBAf,
28%; IF, 7%. It is common for male
mice to develop liver tumours more
readily than females, and of the 20
DBAf mice with liver tumours all but
one were males. In the C57BL mice,
however, the 28 mice with liver tumours
included 10 females. In both strains
these tumours were frequently large
and/or multiple.
A range of histological appearances
was observed, from solid benign hepato-
mata to large hepatocellular carcinomata.
The latter tended to be highly vascular
tumours with large sinusoidal vascular
spaces interspersed between cords and
ribbon-like trabeculae of pleomorphic
hepatocytes (Fig. 4). Large abnormal
mitoses were frequent. In some hepato-
mata tubular and acinar differentiation
were well developed. Areas of necrosis
within the tumour nodules were com-
monly observed. There was no evidence
of bile production. The adjacent normal
liver was commonly compressed around
the periphery of the tumour nodules.
No Kuppfer cell sarcomata were found
but often, within the hepatomata, focal
proliferation of Kuppfer cells was seen
(Fig. 4).
Lung tumours
Strain A mice had lung tumours in
51% at death, the other strains having
incidences of between 23 and 28%.
The strain difference was, however, greater
than appears from the Table in that
many lung tumours in A mice grew to a
large size, those in the other strains
generally not exceeding about 2 mm in
diameter.
The lung tumours were frequently
multiple. The largest lung tumours in
the strain A mice showed histological
features ofmalignancy and a few tumours
had metastasized to the mediastinal
lymph nodes. As with the liver tumours
a range ofhistological types was observed.
The smallest tumours tended to be solid
adenomata of alveolar lining cell origin.
The larger adenomata were composed
of tightly packed collections of regular
cells while others showed a papillary
pattern. In some of these tumours an
adeniform pattern of differentiation was
apparent with cytological features of
malignancy (Fig. 5). Some of the largest
617C. E. SEARLE AND E. L. JONES
FIG. 3.-Male IF mouse, 20 weeks. Cerebellar medulloblastoma consisting of small round cells
infiltrating the outer molecular layer of two adjacent folia. H. and E. x 335.
FIG. 4.-Male DBAf mouse, 55 weeks. Hepatocellular carcinoma, showing abnormal mitosis
and hyperplasia of Kuppfer cells. H. and E. x 335.
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FIG. 5.-Male DBAf mouse, 55 weeks. Large lung tumour composed of closely-packed alveolar
lining cells, showing pleomorphism and mitoses. H. and E. x 335.
tumours observed were well-differentiated
adenocarcinomata, with varying patterns
of differentiation within the one tumour
ranging from distinct acinar patterns to
diffuse sheets of tumour cells. These
tumours resembled malignant alveolar-cell
carcinomata in humans. Local infiltra-
tion of adjacent alveoli, lymphatic and
vascular permeation, and lymph node
metastases were seen.
Lymphomata
These have been grouped together
in the Table but probably include two
histological types. Their incidence ranged
from 0% in the IF mice to 28% in the
DBAf. Many of these tumours were of
thymic origin and often grew to fill much
of the chest cavity before causing death
or acute distress. In other cases the
spleen and lymph nodes were the organs
most obviously involved, while some-
times spleen and thymus were both
greatly enlarged. Thymic tumours pre-
dominated in the DBAf mice, and splenic
in the A and C57BL. They tended to
appear rather earlier than other tumours.
Two main histological types of malig-
nant lymphoma were identified. The
commonest variety closely resembled the
well-differentiated lymphocytic lympho-
ma (lymphosarcoma) of humans. These
tumours were composed of sheets of
uniform small basophilic cells resembling
small lymphocytes and were classified
as small cell lymphomata (lymphocytic
type). The lymph node architecture was
destroyed and replaced by sheets ofdarkly
staining basophilic cells (Fig. 6). Exten-
sive perinodal invasion was usually pres-
ent. When these lymphomata appeared
to have arisen in the thymus, wide-
spread infiltration ofthe mediastinum and
heart was observed. These malignant
lymphomata frequently showed general-
ized involvement of many organs. Ex-
tensive infiltration of the liver was
common, with a tendency for the tumour
cells to be localized around central veins
or portal tracts, reminiscent of lympho-
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FIG. 6. Female A mouse, 52 weeks. Replacement of lymph node architecture by sheets of
small-cell lymphoma (well-differentiated lymphocytic lymphoma). H. and E. x 335.
cytic leukaemic infiltration in humans.
Lung involvement and renal infiltration
were observed in most cases.
Less commonly the lymphomatous
tumours showed a mixture of small
darklymphocytes intermingled with larger
pale cells with oval or reniform vesicular
nuclei and prominent nucleoli. Mitoses
were numerous. These tumours super-
ficially resembled histiocytic lymphomata
(reticulum cell sarcomata) in humans but
the cells were not pyrinophilic and inter-
cellular reticulin fibres were not present.
The precise histogenesis of these cells
was not clear and the tumours were
tentatively classified as large-cell lympho-
mata (probably poorly-differentiated lym-
phocytic). As with the small-cell type,
multi-organ infiltration was very common.
In the lung, peribronchial and peri-
vascular aggregates of tumour cells oc-
curred. With renal involvement the pat-
tern of infiltration resembled leukaemic
infiltration in humans, varying from a
diffuse to a focal infiltrate of lymphoma
cells compressing the existing structures.
An occasional large-cell lymphoma
involving the spleen resembled Hodgkins'
disease, with a few bizarre binucleate
Reed-Sternberg-like cells present. The
large-cell lymphomata appeared to have
arisen most commonly in the thymus
and widely infiltrated the mediastinum,
often showing striking perineural lym-
phatic invasion (Fig. 7).
Other tumours
In addition to the above tumours
a range of miscellaneous tumours was
found in the ENU-treated mice (see
Table). These were of the female repro-
ductive tract (5) and kidney (4), with
isolated examples in various other organs.
The four renal tumours consisted of
two adenomata lined by columnar epi-
thelium with a papillary pattern (papillary
adenomata), and two clear-cell carcino-
mata (hypernephromata). All the renal
tumours were situated in the cortex and
appeared to have arisen from the epi-
thelium of the proximal tubules. In
some mice simple renal cysts were found
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FIG. 7.-Male DBAfmouse, 35 weeks. Diffuse large-cell lymphoma ofthymus showing perineural
permeation. H. and E. x 335.
with hyperplastic epithelial lining cells.
The tumours of the female reproductive
tract were two fibrosarcomata, an angio-
sarcoma and an adenocarcinoma of the
uterus, and a granulosa-cell tumour of
the ovary. Four other fibrosarcomata
were seen, involving the skin, stomach,
intestine and seminal vesicle ofIF mice.
DISCUSSION
The initial stimulus to carrying out
this experiment was the great difference
between rats and mice in their responses
to treatment with carcinogens of the
nitrosamide type, and, particularly at that
time, the apparently complete resist-
ance of mice to carcinogenesis of the
nervous system which occurs in rats with
remarkable ease.
Quite early in the experiment we
did, in fact, find a small proportion of
nervous system tumours in our DBAf
and IF mice and other workers have now
reported similar findings. However, the
proportion of ENU-treated mice which
developed such tumours was small in
our experiment and in those of Vesselino-
vitch and co-workers (1971, 1974) and
Diwan and Meier (1974). The C3HeB/
FeJ mice used by Denlinger, Koestner
and Wechsler (1974) appear unusually
sensitive, with 32.3% developing nervous
system tumours following transplacental
exposure to ENU and 10O5% after MNU.
Despite these interesting findings, how-
ever, it is apparent that ENU preferen-
tially induces tumours in the lung,
lymphoid system or liver of the mouse
rather than in the nervous system, the
actual location of the tumours depending
markedly on strain and method of ad-
ministration.
Mouse strains are well known to
differ greatly in their incidence of spon-
taneous tumours and in their suscepti-
bility to chemical carcinogens, as is
clear from the comprehensive data on
over 240 strains listed by Staats (1972).
Of the strains used in the experiment
reported here, strain A mice are very
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susceptible to the induction of lung
tumours, which also occur spontaneously.
C57BL mice are relatively insensitive to
polycyclic aromatic hydrocarbon carcino-
gens which readily induce leukaemia
in DBAf mice. The less commonly
used IF strain was originally developed
by Dr G. M. Bonser in Leeds and appears
to be unique in having been originally
selected for early development of skin
and ovarian tumours on treatment with
hydrocarbon carcinogens. The wide dif-
ferences in response to the carcinogenic
action of ENIJ shown by the 4 strains in
our experiment were thus to be expected.
In the present experiment also, A
strain mice developed a higher proportion
of lung tumours than did other mice, and
these generally grew much larger than
those in the other strains. The lung
tumours in our series were predomi-
nantly adenomata of alveolar lining
cells, though some of the larger tumours,
especially in the strain A mice, were
malignant alveolar-cell carcinomata simi-
lar to the lung tumours reported by Diwan
and Meier (1974). The smaller adeno-
mata were frequently multiple and often
occurred in connection with lympho-
matous infiltration of the lungs.
Grasso and Crampton (1972) have
put forward the view that induction of
hepatomata in the mouse is not valid
evidence of carcinogenicity, but in sur-
veying the literature on 58 chemicals
tested in the mouse and other species,
Tomatis, Partensky and Montesano (1973)
found a correlation between induction of
hepatomata in mice and induction of
tumours at any site in the rat and ham-
ster. This was strongest when the chemi-
cal induced liver and other tumours in
mice of both sexes. The proceedings of
a workshop on hepatic neoplasia in the
mouse and its significance have recently
been published (Butler and Newberne,
1975).
There is, of course, no doubt about
the carcinogenicity of ENU, which in
our experiment induced liver tumours
in many C57BL and DBAf mice but in
few A and IF mice. In the C57BL mice
18 males and 10 females hadliver tumours,
and in the DBAf mice 19 males and
I female. This accords with the greater
susceptibility of males compared with
females which has often been observed.
Of the 58 mouse liver carcinogens quoted
by Tomatis et al. (1973), 22 affected males
only.
Lymphomata occurred in many A
and DBAf mice, and few C57BL mice
but no IF mice, and these tended to
occur markedly earlier than other tu-
mours. This higher early incidence, par-
ticularly in the DBAf mice, will probably
have reduced the yield of other tumours
which would otherwise have been seen
later.
The lymphomata in our series were
commonly small-cell lymphomata, most
probably well-differentiated lymphocytic
lymphomata (lymphosarcomata). These
tumours were malignant and multi-organ
spreadwas oftenpresent. Many appeared
to have arisen in the thymus and involved
the lungs, heart, spleen, lymph nodes,
liver and kidney, similarly to the lympho-
mata reported by Terracini and Stramig-
noni (1968) in MNU-treated Swiss mice.
Less commonly the malignant lympho-
mata were composed oflarge cells. These
tumours frequently involved the thymus
and showed a similar pattern of spread.
Histologically they resembled histiocytic
lymphomata but we concluded that they
were most probably poorly-differentiated
lymphocytic lymphomata. The occasion-
al splenic large-cell lymphoma contained
a few multinucleated and binucleated
tumour cells resembling Reed-Sternberg
cells.
Renal tumours in mice are rare, and
the few papillary adenomata and clear-
cell carcinomata obtained in our experi-
ments resembled the renal tumours re-
ported by Lombard and Vesselinovitch
(1971) in C3H1 x AFI mice given ENU.
The present experiment shows that
the greater sensitivity of IF mice to
aromatic hydrocarbon carcinogenesis does
not extend to carcinogens of all types.
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Of the treated IF mice examined post
mortem, 28% had lung tumours, almost
all very small, but liver tumours were
rare and no lymphoid tumours were
seen. Just over half of the surviving
treated mice died without tumours. Our
experience with IF mice is that they
are less robust than other better known
strains, also that the females make
poor mothers, and a high proportion
even of saline-treated controls were lost
relatively early in the experiment, though
the very early losses after ENU were
less severe thaninthe C57BLmice (Table).
An earlier experiment (Searle and Spencer,
1966) demonstrated a low response of
IF mice to carcinogenesis by 4-nitro-
quinoline 1-oxide also. IF mice treated
repeatedly with this carcinogen devel-
oped no skin tumours under conditions
which resulted in many carcinomata and
sarcomata in mice of other strains.
As already reported, however, 5 of
the treated IF mice developed tumours of
the nervous system. Of these, 3 were
the only cerebellar medulloblastomata
found in any strain in this experiment,
and they were found at the early times
of 20, 27 and 28 weeks from treatment
(Searle and Jones, 1972, and unpublished).
This led to the hope that the IF mouse
might provide a useful animal model
for the experimental study of medullo-
blastoma. Further tests still in progress
with IF mice and IF x DBAf F1 hybrids
have not so far fulfilled this hope, but
they show that ENU treatment of IF
females during pregnancy results in more
and larger lung tumours in the offspring
than we found after neonatal treatment,
in agreement with Rice's findings in
other strains (1969).
Nitrosamine and various other types
of carcinogen are known to require
enzymatic activation before they are
converted to ultimate carcinogenic agents,
but the less stable nitrosamides such as
ENUi appear to decompose spontaneously
under physiological conditions and to
damage any cells with which they come
into contact (Magee and Swann, 1969).
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It is thus not too surprising that ENUT,
administered to mice of several strains
at a time of rapid cell proliferation,
should induce a variety of tumours as
reported by Diwan and Meier (1974)
and Vesselinovitch et al. (1974) and as
seen in this experiment, and should also
have a deleterious effect on life-span and
resistance to infection in animals which
did not succumb to tumours. It seems
reasonable to suppose that ENLT may
initially affect a correspondingly wide
range of sites in the rat, but that this is
obscured by the great sensitivity of
the rat nervous system to this type
of chemical carcinogenesis.
Some differences in the action of the
closely related ENU and M:NU are of
interest here. As with ENU, there have
been many reports of the induction of rat
nervous system tumours by MNU, but
whereas neonatal treatment of several
rat strains with ENU has induced nervous
system tumours in extremely high yield,
similar treatment of Wistar rats by
Terracini and Testa (1970) with MNU
gave rise to kidney, forestomach, in-
testinal and mammary tumours, with
only one neural tumour in the 32 treated
animals. If these, and other workers
mentioned in theintroduction, had treated
mice with ENU instead of MNU, induc-
tion of nervous system tumours in mice
would probably have been observed
earlier.
The multipotent action of carcino-
gens such as ENU is also relevant to the
problems of human cancer and its causa-
tion. Discussing their extensive studies
of nervous system tumours in the off-
spring of rats treated with ENU during
pregnancy, Ivankovic & Druckrey (1968)
very justifiably emphasized the impor-
tance of protecting women from carcino-
genic agents during pregnancy. That
transplacental carcinogenesis is possible
in man has now been clearly shown by
the occurrence ofvaginal cancer, normally
a very rare condition, in the daughters
of some women who had been treated
during pregnancy with large doses of
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the synthetic hormone diethylstilboestrol
(Herbst et al., 1974). We do not at
present know of an environmental agent
which might have a transplacental car-
cinogenic action in man comparable to
that of ENU in experimental animals,
but the variety of effects seen in ENU-
treated mice suggests that, if such agents
exist, their action might be considerably
more extensive than that of causing
tumours of the nervous system. Other
effects might include not only other
malignancies but possibly also impaired
mental and physical development or
reduced resistance to infection. Perhaps
also possible is sensitization of some
sites to the subsequent action of an
oncogenic virus or other chemical car-
cinogen or co-carcinogen. Identification
and elimination of any such agents might,
on this view, have a considerably greater
beneficial effect than that of reducing
the incidence of cancer alone.
We thank Miss V. Nash, F.I.A.T.,
Miss M. Trumper, F.I.M.L.S. and Mr
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search Campaign for financial support
of C.E.S.
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